drugset / Trial / NCT01293396

Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids

NCT01293396

Phase 4 Completed 20 enrolled Medical University of Graz
RandomizedCrossoverOpen-labelTreatment

Summary

The aim of the study is to investigate meal-related treatment with either premixed Insulin Aspart 30, Aspart 70 and Aspart with regard to postprandial glucose, triglyceride and free fatty acids excursions after a standard breakfast and lunch.

Timeline

Start
2010-06
Primary completion
2011-02
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Aspart 70 Unknown
Comparator Insulin aspart30 Unknown
Comparator insulin aspart Protein / enzyme biologic